Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. (Q47426511)

16 January 2018

title

Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. (English)

1 reference

16 January 2018

adaptive radiation therapy

main subject

0 references

1 reference

Michael J Zelefsky

11

0 references

Deborah Kuban

1

Deborah A Kuban

1 reference

16 January 2018

Lawrence B Levy

3

Larry B Levy

1 reference

16 January 2018

Patrick A. Kupelian

5

Patrick A Kupelian

1 reference

16 January 2018

Eric M Horwitz

4

Eric M Horwitz

1 reference

16 January 2018

Jeff Michalski

7

Jeff M Michalski

1 reference

16 January 2018

Thomas M Pisansky

8

Thomas M Pisansky

1 reference

16 January 2018

Howard Sandler

9

Howard M Sandler

1 reference

16 January 2018

Bill Shipley

10

William U Shipley

1 reference

16 January 2018

Anthony L Zietman

12

Anthony L Zietman

1 reference

16 January 2018

Howard D. Thames

2

Howard D Thames

1 reference

16 January 2018

author name string

Alvaro A Martinez

6

1 reference

16 January 2018

language of work or name

English

0 references

publication date

1 November 2003

1 reference

16 January 2018

International Journal of Radiation Oncology Biology Physics

published in

1 reference

16 January 2018

volume

57

1 reference

16 January 2018

issue

4

1 reference

16 January 2018

page(s)

915-928

1 reference

16 January 2018

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900632-1

7 January 2021

Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900632-1

7 January 2021

A multiple prognostic index predictive of disease outcome after irradiation for clinically localized prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900632-1

7 January 2021

Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900632-1

7 January 2021

Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900632-1

7 January 2021

Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900632-1

7 January 2021

Grading inaccuracies in diagnostic biopsies revealing prostatic adenocarcinoma: implications for definitive radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900632-1

7 January 2021

Changing prostate-specific antigen outcome after surgery or radiotherapy for localized prostate cancer during the prostate-specific antigen era

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900632-1

7 January 2021

The importance of adequate follow-up in defining treatment success after external beam irradiation for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900632-1

7 January 2021

Practical application of biochemical failure definitions: what to do and when to do it

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900632-1

7 January 2021

Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900632-1

7 January 2021

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900632-1

7 January 2021

HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED PROSTATE CANCER

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900632-1

7 January 2021

Importance of high radiation doses (72 Gy or greater) in the treatment of stage T1-T3 adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900632-1

7 January 2021

A standard definition of disease freedom is needed for prostate cancer: undetectable prostate specific antigen compared with the American Society of Therapeutic Radiology and Oncology consensus definition

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2803%2900632-1

7 January 2021

10.1016/S0360-3016(03)00632-1

Identifiers

DOI

1 reference

16 January 2018

1 reference

16 January 2018